QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.8 % of QIAGEN's outstanding common shares at the end of January 2019.
|BlackRock, Inc., United States||21,835||9.46|
|PRIMECAP Management Company, United States||15,905||6.89|
|MFS Investment Management, United States||13,110||5.68|
|Wellington Management Company, United States||9,957||4.31|
|Deutsche Asset Management, Germany||7,460||3.23|
Status: March 2019